Home Axela

Axela

acquired
-
A Biotechnology Company

Basic Information

Axela offers a unique next-generation, commercial-stage, multiplexing toolkit for enhanced protein, DNA, and RNA analysis. Our product suite is specifically targeted at biomarker testing and infectious disease research, designed to facilitate the transition to personalized medicine. They are commercialized through distributors in the life science and clinical research markets, with specific applications licensed to diagnostic or industry segment partners. Our product portfolio includes instruments, consumables (sensors, chips, and reagents), and applications (biomarker content, analytical methods, and software).
Axela Inc.
Toronto,Ontario,Canada
unclear
January 01, 2001
supportservices@axela.com